Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes

Haematologica

Volumn 96, Issue 4, 2011, Pages 602-606

  Feng, Xingmin ^a   Scheinberg, Phillip ^a   Wu, Colin O ^a   Samsel, Leigh ^a   Nunez, Olga ^a   Prince, Courtney ^b   Ganetzky, Rebecca D ^c   Philip McCoy, J ^a   Maciejewski, Jaroslaw P ^b   Young, Neal S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

^c CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

Aplastic anemia; Cytokine; Myelodysplastic syndromes

Indexed keywords

CD40 LIGAND; CXCL11 CHEMOKINE; CYTOKINE; EOTAXIN; EPIDERMAL GROWTH FACTOR; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RANTES; SCATTER FACTOR; THROMBOPOIETIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

APLASTIC ANEMIA; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MYELODYSPLASTIC SYNDROME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, APLASTIC; BLOOD CELLS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; CYTOKINES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; YOUNG ADULT;

EID: 79953891819     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.030536     Document Type: Article

References (16)

1. Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006;108(8):2509-25019.
2. Barrett J, Saunthararajah Y, Molldrem J. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology? Semin Hematol. 2000;37(1):15-29.
3. Kaushansky K, Broudy VC, Harlan JM, Adamson JW. Tumor necrosis factor-alpha and tumor necrosis factor-beta (lymphotox-in) stimulate the production of granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and IL-1 in vivo. J Immunol. 1988;141(10): 3410-3415.
4. Linenberger ML, Jacobson FW, Bennett LG, Broudy VC, Martin FH, Abkowitz JL. Stem cell factor production by human marrow stromal fibroblasts. Exp Hematol. 1995;23 (10):1104-1114.
5. Hirayama Y, Sakamaki S, Matsunaga T, et al. Concentrations of thrombopoietin in bone marrow in normal subjects and in patients with idiopathic thrombocytopenic purpura, aplastic anemia, and essential thrombocythemia correlate with its mRNA expression of bone marrow stromal cells. Blood. 1998;92(1):46-52.
6. Marsh JC, Gibson FM, Prue RL, et al. Serum thrombopoietin levels in patients with aplastic anaemia. Br J Haematol. 1996;95 (4):605-610.
7. Kojima S, Matsuyama T, Kodera Y, Tahara T, Kato T. Measurement of endogenous plasma thrombopoietin in patients with acquired aplastic anaemia by a sensitive enzyme-linked immunosorbent assay. Br J Haematol. 1997;97(3):538-543.
8. Kojima S, Matsuyama T, Kodera Y, et al. Measurement of endogenous plasma gran-ulocyte colony-stimulating factor in patients with acquired aplastic anemia by a sensitive chemiluminescent immunoassay. Blood. 1996;87(4):1303-1308.
9. Takeichi N, Umemura T, Nishimura J, Motomura S, Kozuru M, Ibayashi H. Regulation of erythropoietin and burst-promoting activity production in patients with aplastic anemia and iron deficiency anemia. Acta Haematol. 1988;80(3):145-152.
10. Stasi R, Brunetti M, Bussa S, et al. Serum levels of tumour necrosis factor-alpha predict response to recombinant human ery-thropoietin in patients with myelodysplas- tic syndrome. Clin Lab Haematol. 1997;19 (3):197-201.
11. Tamura H, Ogata K, Luo S, et al. Plasma thrombopoietin (TPO) levels and expression of TPO receptor on platelets in patients with myelodysplastic syndromes. Br J Haematol. 1998;103(3):778-784.
12. Rosenfeld SJ, Kimball J, Vining D, Young NS. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood. 1995;85(11):3058-3065.
13. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100(7):2292-2302.
14. Cheson BD, Bennett JM, Kantarjian H, et al. Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood. 2000; 96(12):3671-3674.
15. Bristow CA, Shore P. Transcriptional regulation of the human MIP-1alpha promoter by RUNX1 and MOZ. Nucleic Acids Res. 2003;31(11):2735-2744.
16. Scheinberg P, Wu CO, Nunez O, Young NS. Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine. J Pediatr. 2008;153(6):814-819.